Harnessing immunogenic cell death mechanisms to trigger antitumour immunity

Lead Research Organisation: Institute of Cancer Research
Department Name: Division of Breast Cancer Research


Death is not an endpoint, but the beginning of a novel communication axis between dying cells and cells of the immune system. The way in which a cell dies dramatically alters the danger signals that get released. While apoptosis tilts towards an immunologic silent outcome, non-apoptotic forms of cell death, such as caspase-independent necroptosis, can be highly immunogenic. The successful PhD candidate will investigate how non-apoptotic cell death mechanisms can be used to open a new line of communication with immune cells. Specifically, he/she will use ICR-developed PROTAC degraders in combination with radiation therapy to rewire cell death signalling pathways into caspaseindependent forms of cell death. We will test whether killing cancer cells by non-apoptotic forms of cell death more effectively drives an immune response against tumours, hence enhancing the effectiveness of radiotherapy.


10 25 50

Studentship Projects

Project Reference Relationship Related To Start End Student Name
MR/W006553/1 01/10/2022 30/09/2028
2748290 Studentship MR/W006553/1 03/10/2022 02/10/2026 Maria Fernandez Goicoechea